Investigating how genes affect resilience to toxic substances
CRISPR screens of population relevant genes governing toxicant resilience
This study is looking at how our genes might affect how we react to harmful chemicals and toxins, which could help us find out who might be more at risk and lead to better ways to protect people from these dangers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11249698 on NIH RePORTER |
What this research studies
This research explores how different genetic factors influence individual responses to chemical and biological toxins. By identifying common human genetic variants that affect resilience to these toxicants, the study aims to uncover key gene-environment interactions. The approach involves a systematic examination of 1490 genes known to interact with various toxins, which could help in identifying individuals at risk of adverse health outcomes. This research could lead to improved preventive strategies for those exposed to harmful substances.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been exposed to chemical or biological toxins and may have varying responses based on their genetic makeup.
Not a fit: Patients who have not been exposed to any toxic substances or those with no genetic variations related to toxin resilience may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of genetic susceptibility to toxins, leading to better prevention and treatment strategies for affected individuals.
How similar studies have performed: Previous research has shown promise in identifying gene-environment interactions, but this approach of systematically targeting specific genes related to toxin resilience is relatively novel.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Vulpe, Christopher D — University of Florida
- Study coordinator: Vulpe, Christopher D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.